Relaxin-2 does not ameliorate nephropathy in an experimental model of type-1 diabetes.
Dschietzig TB, Krause-Relle K, Hennequin M, von Websky K, Rahnenführer J, Ruppert J, Grön HJ, Armbruster FP, Bathgate RA, Aschenbach JR, Forssmann WG, Hocher B.
Dschietzig TB, et al. Among authors: gron hj.
Kidney Blood Press Res. 2015;40(1):77-88. doi: 10.1159/000368484.
Kidney Blood Press Res. 2015.
PMID: 25791819
Free article.